•   
  •   
  •   

Canada AstraZeneca Vaccine: EMA has not identified a particular risk of

19:25  17 september  2021
19:25  17 september  2021 Source:   rfi.fr

‘Vaccine passport’ or ‘immunization record’? Why experts say there’s power in words

  ‘Vaccine passport’ or ‘immunization record’? Why experts say there’s power in words The concept of 'vaccine passports' were first introduced last year, when COVID-19 vaccines were still undergoing clinical tests in laboratories run by pharmaceutical giants.Liberals cancelled a campaign stop in Ontario due to "safety concerns." A sign depicted Trudeau being executed by hanging emerged, held by a member of the crowd. And on Tuesday, protesters began hurling small rocks.

Sant Coronavirus-AstraZeneca-Europe thrombosis: AstraZeneca vaccine: EMA has not identified a particular risk of Thromboses

VACCIN ASTRAZENECA: L'EMA N'A PAS IDENTIFIÉ UN RISQUE PARTICULIER DE THROMBOSES © Reuters / Dado RUVIC Vaccine AstraZeneca: EMA has not identified a particular risk of Thromboses

(Reuters) - The European Medicines Agency (EMA) said Friday can not confirm, on the basis of available data, the existence of a Increased risk of atypical thromboses in women and adolescents vaccinated with Astrazeneca against CVIV-19.

The European drug regulator could not identify a specific risk factor that could increase the incidence rate of thrombocytopenic thrombotic syndrome (STT) - blood clots associated with low platelet ratio - due to a collection Parcel of information, he said.

Navigating a COVID-19 vaccine passport society won't be easy for those who remain unvaccinated

  Navigating a COVID-19 vaccine passport society won't be easy for those who remain unvaccinated Those in Canada who are not vaccinated against COVID-19, for whatever reason, will see their access to restaurants, events and even some employment stripped away — leaving many feeling ostracized, experts say.Maharaj has been fully vaccinated with the Quebec-based Medicago trial vaccine since April.

The EMA reaffirmed that this vaccine, developed in collaboration with the University of Oxford and renamed Vaxzeria, was to be administered in two doses, with an interval of 4 to 12 weeks between the first and the second injection.


Video: Laurent Uzan, Doctor: "There is no longer any medical wandering" For the patients of the Long Covid (France 24)

"Nothing proves that delaying the Second dose has any influence on the risk of STT, "said EMA.

The European Medicines Agency has also clarified that it could not currently make a definitive recommendation on the combination of different coronavirus vaccines with AstraZeneca.

Many European countries have suspended the use of this vaccine after coagulation disorders reported among vaccinated people, some of which have led to death.

(Pushkala Aripaka report in Bangalore, French version Anait Miridzhanian)

COVID-19 live updates: Quebec reports 701 cases, 2 deaths as hospitalizations jump .
Updated throughout the day on Friday, Sept. 24. Questions/comments: ariga@postmedia.com Top updates If Roberge were a woman, Legault would have fired him, Liberal critic says Montreal Canadiens to get government financial support for mural promoting downtown workplaces A Montreal regional health authority is calling 2,000 former workers, encouraging them to return – Dubé Quebec reports 701 cases, 2 deaths as hospitalizations jump Live: Federal health officials provide COVID-19 update Study got calculation wrong, exaggerating risk of heart inflammation after COVID vaccine Quebec announces new mask rules for private seniors’ residences in some regions Young children ha

usr: 1
This is interesting!